These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported Terminated 2005-004234-41 Dosisdichte 1st-line Therapie des metastasierten Mammakarzinoms mit Paclitaxel und liposomalem Doxorubicin (Myocet®) 2014-03-31 due-trials
Ongoing 2006-002006-60 Functional neuroanatomy and regional metabolism in depressed patients with quetiapin: An fMRI-guided MRS study on a 7 Tesla scanner not-yet-due
Ongoing 2006-002346-11 Stereoselective pharmacokinetics and CYP2C19-genotyping as outcome predictors of an omeprazole therapy in patients with GERD -- a pilot study (phase IV-study) not-yet-due
Completed, but no date 2007-002031-92 Proliferation and differentiation markers, involved in erosive and non-erosive reflux esophagitis, Barrett´s esophagus and esophageal adenocarcinoma. bad-data
Not reported 2007-002331-89 Randomisierte Phase II Studie zur Therapieoptimierung der Behandlung des hormonrefraktären Prostatakarzinoms mit Docetaxel + Prednison versus Docetaxel + Prednison + low dose Cyclophosphamid 2011-11-24 due-trials
Completed, but no date Terminated 2007-003262-17 Impact of irbesartan on oxidative stress and C-reactive protein levels in patients with persistent atrial fibrillation bad-data
Ongoing 2008-001302-16 Stereoselective pharmacokinetics and CYP2C19-genotyping as outcome predictors of an esomeprazole therapy in patients with GERD -- a pilot study (phase IV-study) not-yet-due
Completed, but no date 2008-002985-70 Evaluation of the preventive effect of pentoxifylline and ursodeoxycholic acid to radiation induced liver toxicity after brachytherapy of liver metastases, assessed in a prospective randomised trial. bad-data
Ongoing 2008-003120-37 EV(E)A Studie Estriol versus Estradiol - Eine prospektive, randomisierte Multizenterstudie zur Evaluation der Wirkung einer lokalen Therapie auf urogenitale Beschwerden, Zytologie und Mammographiedic... not-yet-due
Not reported 2008-004991-28 Assessment of focal liver lesions in fluoroscopic MR using Primovist and fast dynamic imaging sequences for interventional purposes 2009-08-19 due-trials
Not reported 2008-005609-21 Exploratory study to assess the predictive value of 99mTc-labeled albumin spheres for the intrahepatic distribution of 90Y SIR Spheres in patients with liver metastases of colorectal tumors. 2013-08-30 due-trials
Completed, but no date 2008-006227-31 Inflammatory Topoproteome of Psoriasis under Etanercept Treatment bad-data
Ongoing 2009-011093-15 The role of the neurotransmitters dopamine and acetylcholine in the interaction of selective attention and working memory. not-yet-due
Listed as ongoing, but also has a completion date 2009-012576-27 Evaluación de Sorafenib en combinación con microterapia local guiada por RM con contraste Gd-EOB-DTPA en pacientes con carcinoma hepatocelular inoperable 2019-01-30 bad-data
Not reported 2009-012706-39 Multicentric, open-label, single-arm phase II study with oral lapatinib in combination with oral capecitabine plus intrathecally administered liposomal cytarabine (DepoCyte®) for the treatment of meni... 2013-11-26 due-trials
Ongoing 2010-018279-99 Skin Topoproteome under Adalimumab (Humira®) Treatment in Patients with Moderate to Severe Psoriasis not-yet-due
Not reported 2010-018517-29 Topoproteome-Analysis of Psoriasis under Fumarate-Treatment. 2011-09-07 due-trials
Completed, but no date 2010-022864-12 Effect of Omalizumab (Xolair) on the threshold of degranulation and the composition of intracellular granules in skin mast cells and peripheral basophilic granulocytes before and during omalizumab the... bad-data
Not reported 2010-023414-31 Ketamine in treatment resistant major depression (TRD) 2016-04-22 due-trials
Completed, but no date 2010-023901-36 Psoriasis-topoproteome under ustekinumab treatment (PIROUETTE-Study) - as an interventional observation study (phase IV) within approved label and indication and with minimal invasive taking of skin b... bad-data
Not reported 2011-000152-42 An evaluator-blind controlled parallel-group study to assess efficacy and safety of Skinoren 15% gel and Differin 0.1 % gel for the treatment and maintenance treatment of facial acne vulgaris and late... 2012-10-15 due-trials
Ongoing 2011-001765-41 Single-arm, open-label, multicentre phase II study evaluating the efficacy and safety of BIBW 2992 (Afatinib) in combination with vinorelbine for the treatment of patients with metastatic breast cance... not-yet-due
Not reported Terminated 2016-002735-16 Correlation between common clinical outcome parameters, CTC-changes and ARV7-status (androgen receptor splice variant 7) in patients with mCRPC treated with first line abiraterone acetat (Zytiga®) 2018-08-30 due-trials
Ongoing 2018-000342-19 Prospective, randomized, double-blind clinical trial phase II for the anti-inflammatory effects of Curazink (zinc histidine) for 8 weeks in elderly patients with mild cognitive impairment in Alzheimer... not-yet-due